Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion

Spine Journal

Volumn 10, Issue 9, 2010, Pages

  Muchow, Ryan D ^a   Hsu, Wellington K ^b   Anderson, Paul A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

BMP; Inflammatory; Radiculopathy; Transforaminal lumbar interbody fusion

Indexed keywords

ANTIINFLAMMATORY AGENT; GADOLINIUM; NARCOTIC ANALGESIC AGENT; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; ARTICLE; CASE REPORT; DECOMPRESSION SURGERY; DEGENERATIVE DISEASE; EOSINOPHIL; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LEG; LOW BACK PAIN; LUMBAR SPINE; LYMPHOCYTE; MALE; NERVE ROOT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; RADICULOPATHY; RADIODIAGNOSIS; RADIOLOGY; SPINE FUSION; TRANSFORAMINAL LUMBAR INTERBODY FUSION;

ADULT; BONE MORPHOGENETIC PROTEINS; HUMANS; INFLAMMATION; INTERVERTEBRAL DISK DEGENERATION; LUMBAR VERTEBRAE; MALE; OFF-LABEL USE; POSTOPERATIVE COMPLICATIONS; RADICULOPATHY; RECOMBINANT PROTEINS; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956140416     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2010.06.020     Document Type: Article

References (23)

1. G.J. Martin Jr., S.D. Boden, and L. Titus Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion Spine 24 1999 2188 2193 discussion 2193-4
2. B. Perri, M. Cooper, C. Lauryssen, and N. Anand Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study Spine J 7 2007 235 239
3. Sanfilippo JA, Lee JY, Rihn J, et al. Increased post-operative radiculitis when BMP-2 is used with transforaminal interbody fusion. AAOS Annual Meeting; March 5-7, 2008; San Francisco, CA.
4. Sanfilippo JA, Lee JY, Rihn J, et al. BMP-2 causes increased post-operative radiculitis following TLIF. NASS Annual Meeting; October 23-27, 2007; Austin, TX.
5. L.B. Shields, G.H. Raque, and S.D. Glassman Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion Spine 31 2006 542 547
6. J.D. Smucker, J.M. Rhee, and K. Singh Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine Spine 31 2006 2813 2819
7. P.J. Slosar, R. Josey, and J. Reynolds Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes Spine J 7 2007 301 307
8. R.W. Haid Jr., C.L. Branch Jr., J.T. Alexander, and J.K. Burkus Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages Spine J 4 2004 527 538 discussion 538-9
9. V. Joseph, and Y.R. Rampersaud Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis Spine 32 2007 2885 2890
10. J.W. McClellan, D.S. Mulconrey, R.J. Forbes, and N. Fullmer Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2) J Spinal Disord Tech 19 2006 483 486
11. P.V. Mummaneni, J. Pan, R.W. Haid, and G.E. Rodts Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the joint section meeting on disorders of the spine and peripheral nerves, March 2004 J Neurosurg Spine 1 2004 19 23
12. C.H. Crawford 3rd, L.Y. Carreon, and M.D. McGinnis Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis Spine 34 2009 1390 1394
13. H.J. Meisel, M. Schnoring, and C. Hohaus Posterior lumbar interbody fusion using rhBMP-2 Eur Spine J 17 2008 1735 1744
14. J.A. Rihn, R. Patel, and J. Makda Complications associated with single-level transforaminal lumbar interbody fusion Spine J 9 2009 623 629
15. D.A. Wong, A. Kumar, and S. Jatana Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2) Spine J 8 2008 1011 1018
16. R. Vaidya, A. Sethi, and S. Bartol Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions J Spinal Disord Tech 21 2008 557 562
17. N.F. Chen, Z.A. Smith, and E. Stiner Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion J Neurosurg Spine 12 2010 40 46
18. A. Marusic, D. Grcevic, and V. Katavic Role of B lymphocytes in new bone formation Lab Invest 80 2000 1761 1774
19. A. Marusic, V. Katavic, D. Grcevic, and I.K. Lukic Genetic variability of new bone induction in mice Bone 25 1999 25 32
20. W.K. Hsu, and J.R. Lieberman The role of bone graft substitutes in total hip arthroplasty J.J. Callaghan, A.G. Rosenberg, H.E. Rubash, The adult hip 2nd ed. 2007 Lippincott Williams & Wilkins Philadelphia, PA 329 334
21. H. Zhang, D.J. Sucato, and R.D. Welch Recombinant human bone morphogenic protein-2-enhanced anterior spine fusion without bone encroachment into the spinal canal: a histomorphometric study in a thoracoscopically instrumented porcine model Spine 30 2005 512 518
22. A.T. Villavicencio, S. Burneikiene, and E.L. Nelson Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2 J Neurosurg Spine 3 2005 436 443
23. V.V. Patel, L. Zhao, and P. Wong Controlling bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue Spine 31 2006 1201 1206